NasdaqCM - Nasdaq Real Time Price USD
ENDRA Life Sciences Inc. (NDRA)
3.8001
+0.3301
+(9.49%)
As of 2:26:40 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-7,400.5470
-7,400.5470
-9,548.7750
-12,769.3710
-11,122.3840
Investing Cash Flow
-12.7960
-12.7960
-24.7210
-202.5770
-45
Financing Cash Flow
7,808.9170
7,808.9170
7,518.3050
8,399.5120
13,401.6020
End Cash Position
3,229.4800
3,229.4800
2,833.9070
4,889.0980
9,461.5340
Interest Paid Supplemental Data
31.9100
31.9100
44.9850
59.1130
57.6550
Capital Expenditure
-16
-16
-33.8840
-202.5770
-45
Issuance of Capital Stock
1,148.4700
1,148.4700
6,483.3930
8,399.5120
10,615.9750
Repayment of Debt
-28.4840
-28.4840
--
--
--
Free Cash Flow
-7,416.5470
-7,416.5470
-9,582.6590
-12,971.9480
-11,167.3840
12/31/2021 - 6/30/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
APDN Applied DNA Sciences, Inc.
0.8338
-3.28%
ISPC iSpecimen Inc.
1.2300
+1.23%
PRPO Precipio, Inc.
6.03
-10.40%
PRPH ProPhase Labs, Inc.
0.3485
+3.97%
BDSX Biodesix, Inc.
0.5706
-0.11%
MYNZ Mainz Biomed N.V.
3.4270
+7.09%
ACRS Aclaris Therapeutics, Inc.
1.3400
+5.51%
TTOO T2 Biosystems, Inc.
0.1105
+0.45%
NEOG Neogen Corporation
5.12
-1.54%
BIAF bioAffinity Technologies, Inc.
0.4993
-2.48%